We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+25.31%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$615M
AUM Growth
-$26.4M
Cap. Flow
-$90.4M
Cap. Flow %
-14.7%
Top 10 Hldgs %
10.02%
Holding
357
New
126
Increased
9
Reduced
90
Closed
116

Top Buys

Rank Stock Value
1
FTAI icon
FTAI Aviation
FTAI
+$5.42M
2
CBT icon
Cabot Corp
CBT
+$4.61M
3
BCO icon
Brink's
BCO
+$4.45M
4
FORM icon
FormFactor
FORM
+$4.43M
5
BMI icon
Badger Meter
BMI
+$4.35M

Sector Composition

Rank Sector Weight
1 Industrials 26.41%
2 Technology 22.84%
3 Healthcare 18.79%
4 Consumer Discretionary 10.92%
5 Financials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTI icon
226
Universal Technical Institute
UTI
$1.53B
$521K 0.08%
33,099
-41,354
-56% -$619K
GIFI
227
DELISTED
Gulf Island Fabrication
GIFI
$518K 0.08%
85,346
VRCA icon
228
Verrica Pharmaceuticals
VRCA
$92.6M
$515K 0.08%
+7,059
New +$542K
STOK icon
229
Stoke Therapeutics
STOK
$2.06B
$508K 0.08%
37,637
-8,208
-18% -$111K
ELMD icon
230
Electromed
ELMD
$347M
$491K 0.08%
32,679
-7,728
-19% -$121K
JSPR icon
231
Jasper Therapeutics
JSPR
$21.8M
$489K 0.08%
21,525
EU
232
enCore Energy
EU
$223M
$484K 0.08%
122,894
LWAY icon
233
Lifeway Foods
LWAY
$475M
$467K 0.08%
36,555
PPTA
234
Perpetua Resources
PPTA
$2.85B
$458K 0.07%
+87,986
New +$523K
CRMD icon
235
CorMedix
CRMD
$588M
$454K 0.07%
+104,894
New +$533K
BLND icon
236
Blend Labs
BLND
$472M
$450K 0.07%
190,711
-67,820
-26% -$180K
BYRN icon
237
Byrna Technologies
BYRN
$98.7M
$424K 0.07%
42,487
-49,294
-54% -$608K
SYRE icon
238
Spyre Therapeutics
SYRE
$9.11B
$422K 0.07%
17,938
HCI icon
239
HCI Group
HCI
$2.31B
$418K 0.07%
4,537
-29,837
-87% -$3.11M
CATX icon
240
Perspective Therapeutics
CATX
$338M
$325K 0.05%
32,631
-51,685
-61% -$747K
ELUT icon
241
Elutia
ELUT
$38.9M
$125K 0.02%
+25,260
New +$82.1K
AAON icon
242
Aaon
AAON
$7.39B
-62,621
Closed -$5.52M
ACLX
243
DELISTED
Arcellx
ACLX
-66,052
Closed -$4.59M
AGO icon
244
Assured Guaranty
AGO
$3.66B
-44,313
Closed -$3.87M
AGS
245
DELISTED
PlayAGS
AGS
-101,742
Closed -$916K
AIT icon
246
Applied Industrial Technologies
AIT
$13.3B
-29,927
Closed -$5.91M
AKBA icon
247
Akebia Therapeutics
AKBA
$256M
-428,549
Closed -$784K
ALSN icon
248
Allison Transmission
ALSN
$9.64B
-53,504
Closed -$4.34M
ANF icon
249
Abercrombie & Fitch
ANF
$4.91B
-27,234
Closed -$3.41M
APG icon
250
APi Group
APG
$17.8B
-157,898
Closed -$4.13M

Similar funds

EAM Investors's Q2 2024 Portfolio in Review

As of Q2 2024, EAM Investors held 357 positions worth $615M, down 4.1% from $642M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

EAM Investors withdrew a net $90.4M in Q2 2024, closing 116 positions and reducing 90 holdings. Its most notable exit was Viking Therapeutics, an estimated $5.99M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

Against the trend, EAM Investors opened a new position in FTAI Aviation worth $7.04M.

  • EAM Investors's largest Q2 2024 buy was FTAI Aviation: 68,171 shares worth $7.04M.
  • EAM Investors added most to American Superconductor in Q2 2024, an estimated $2.33M increase.
  • EAM Investors's biggest Q2 2024 reduction was Super Micro Computer, cutting an estimated $5.21M.
  • EAM Investors fully exited Viking Therapeutics in Q2 2024, selling an estimated $5.99M.
  • EAM Investors's ten largest holdings make up 10% of its $615M portfolio in Q2 2024.
  • EAM Investors opened 126 new positions and closed 116 in Q2 2024.
  • EAM Investors's portfolio value fell 4.1% quarter-over-quarter to $615M.

Based on EAM Investors's 13F filing for Q2 2024, filed 12 Aug 2024.